It could be that individual vaccines are particularly suitable for certain population groups? for example for the elderly. The Vaccination Commission has the task of setting priorities in the event that a vaccine is initially only available in limited quantities.
"When asked who should be vaccinated first, we always have to ask who is at the highest risk of infection and who would benefit most from a vaccination," says Wicker. Such a risk-benefit analysis is a central element of Stiko's standardized approach. "In the current case, the groups in particular need of protection include the medical staff as well as the chronically ill and the elderly," said the vice-chairwoman. The Stiko already set up a working group in spring to develop vaccination recommendations in the corona pandemic.
"We cannot wait until a specific Sars-CoV-2 vaccine is approved, but have to set a framework for recommendations in advance," said the doctor.